Matches in SemOpenAlex for { <https://semopenalex.org/work/W168539731> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W168539731 endingPage "8" @default.
- W168539731 startingPage "13" @default.
- W168539731 abstract "Cisplatin-based chemotherapy is effective in non-small cell lung cancer (NSCLC), although it prolongs survival only modestly. Single-agent docetaxel (Taxotere; Rhône-Poulenc Rorer, Antony, France) is highly active against NSCLC. The activity and tolerability of two docetaxel/ cisplatin regimens were therefore investigated in two multicenter phase II studies, one in Australia and one in France. Chemotherapy-naive patients with inoperable NSCLC received either docetaxel 75 mg/m2 on day 1 plus cisplatin 75 mg/m2 3 weekly (n = 47; Australian study) or docetaxel 75 mg/m2 on day 1 plus cisplatin 100 mg/m2 every 3 weeks for three cycles then every 6 weeks (n = 51; French study). The majority of the population (74%) had metastatic disease. Seventy-eight patients were evaluable for efficacy. Overall response rates were 36% (95% confidence interval, 25 to 47) in all evaluable patients and 34% in patients with metastases. Median duration of response was 6 months, with a 4-month median time to progression. Median survival time was 9 months, with a 1-year survival rate of 34%. A median of four (range, one to nine) treatment cycles were administered. Febrile neutropenia occurred in 14% of patients. Severe infection, which occurred in less than 7% of patients, led to two toxic deaths. Other severe toxicities were rare, with severe stomatitis and severe neurosensory side effects reported in 2% and 1%, respectively, of treated patients. No severe fluid retention occurred. Docetaxel/cisplatin, administered as two different schedules, is well tolerated and exhibits efficacy in the range of the most established combinations in the treatment of advanced NSCLC." @default.
- W168539731 created "2016-06-24" @default.
- W168539731 creator A5017495356 @default.
- W168539731 creator A5038498358 @default.
- W168539731 creator A5040609777 @default.
- W168539731 creator A5040653552 @default.
- W168539731 creator A5050904631 @default.
- W168539731 creator A5051058478 @default.
- W168539731 creator A5065114519 @default.
- W168539731 creator A5066167770 @default.
- W168539731 creator A5066325139 @default.
- W168539731 creator A5072697830 @default.
- W168539731 creator A5079833339 @default.
- W168539731 creator A5088697715 @default.
- W168539731 date "1999-06-01" @default.
- W168539731 modified "2023-09-27" @default.
- W168539731 title "Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer." @default.
- W168539731 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10458205" @default.
- W168539731 hasPublicationYear "1999" @default.
- W168539731 type Work @default.
- W168539731 sameAs 168539731 @default.
- W168539731 citedByCount "7" @default.
- W168539731 countsByYear W1685397312017 @default.
- W168539731 crossrefType "journal-article" @default.
- W168539731 hasAuthorship W168539731A5017495356 @default.
- W168539731 hasAuthorship W168539731A5038498358 @default.
- W168539731 hasAuthorship W168539731A5040609777 @default.
- W168539731 hasAuthorship W168539731A5040653552 @default.
- W168539731 hasAuthorship W168539731A5050904631 @default.
- W168539731 hasAuthorship W168539731A5051058478 @default.
- W168539731 hasAuthorship W168539731A5065114519 @default.
- W168539731 hasAuthorship W168539731A5066167770 @default.
- W168539731 hasAuthorship W168539731A5066325139 @default.
- W168539731 hasAuthorship W168539731A5072697830 @default.
- W168539731 hasAuthorship W168539731A5079833339 @default.
- W168539731 hasAuthorship W168539731A5088697715 @default.
- W168539731 hasConcept C121608353 @default.
- W168539731 hasConcept C126322002 @default.
- W168539731 hasConcept C141071460 @default.
- W168539731 hasConcept C143998085 @default.
- W168539731 hasConcept C197934379 @default.
- W168539731 hasConcept C2776256026 @default.
- W168539731 hasConcept C2776694085 @default.
- W168539731 hasConcept C2777063308 @default.
- W168539731 hasConcept C2778239845 @default.
- W168539731 hasConcept C2778375690 @default.
- W168539731 hasConcept C2778850193 @default.
- W168539731 hasConcept C2781190966 @default.
- W168539731 hasConcept C2908647359 @default.
- W168539731 hasConcept C71924100 @default.
- W168539731 hasConcept C90924648 @default.
- W168539731 hasConcept C99454951 @default.
- W168539731 hasConceptScore W168539731C121608353 @default.
- W168539731 hasConceptScore W168539731C126322002 @default.
- W168539731 hasConceptScore W168539731C141071460 @default.
- W168539731 hasConceptScore W168539731C143998085 @default.
- W168539731 hasConceptScore W168539731C197934379 @default.
- W168539731 hasConceptScore W168539731C2776256026 @default.
- W168539731 hasConceptScore W168539731C2776694085 @default.
- W168539731 hasConceptScore W168539731C2777063308 @default.
- W168539731 hasConceptScore W168539731C2778239845 @default.
- W168539731 hasConceptScore W168539731C2778375690 @default.
- W168539731 hasConceptScore W168539731C2778850193 @default.
- W168539731 hasConceptScore W168539731C2781190966 @default.
- W168539731 hasConceptScore W168539731C2908647359 @default.
- W168539731 hasConceptScore W168539731C71924100 @default.
- W168539731 hasConceptScore W168539731C90924648 @default.
- W168539731 hasConceptScore W168539731C99454951 @default.
- W168539731 hasIssue "3 Suppl 11" @default.
- W168539731 hasLocation W1685397311 @default.
- W168539731 hasOpenAccess W168539731 @default.
- W168539731 hasPrimaryLocation W1685397311 @default.
- W168539731 hasRelatedWork W149905810 @default.
- W168539731 hasRelatedWork W1973241390 @default.
- W168539731 hasRelatedWork W2021538943 @default.
- W168539731 hasRelatedWork W2031554341 @default.
- W168539731 hasRelatedWork W2273140211 @default.
- W168539731 hasRelatedWork W2347520915 @default.
- W168539731 hasRelatedWork W2362206945 @default.
- W168539731 hasRelatedWork W3155373832 @default.
- W168539731 hasRelatedWork W4231274199 @default.
- W168539731 hasRelatedWork W4234460536 @default.
- W168539731 hasVolume "26" @default.
- W168539731 isParatext "false" @default.
- W168539731 isRetracted "false" @default.
- W168539731 magId "168539731" @default.
- W168539731 workType "article" @default.